Blockchain-based data storage: Dwinity opens new possibilities for Predictive AI

- Dwinity enables consumers and organizations to store and use sensitive data in a secure and completely anonymized environment, access to the trial phase possible since August
- Predictive AI is at the heart of the blockchain-based data ecosystem
- The tech startup's seed funding was completed under the new MiCAR regulation for crypto assets; the next round will occur as a private token sale
Munich, September 4, 2024 - Current methods of using big data and AI are far from sufficient to publish new trustworthy AI applications - there is still a lack of high-quality data. Only a decentralized solution for data storage can help people make their most valuable data available for the common good or for use in commercial research.
Dwinity, a German tech startup from Munich, is tackling this problem with a data ecosystem centered around a decentralized, secure and anonymous storage location for sensitive personal data. Dwinity is now giving first test users access to this storage location.
Users register through their wallet address as they usually do in the blockchain environment using the page https://dwinity.com/app/. This means that access is always possible regardless of the device or authentication method. Access to this stage is primarily granted to the community, whose desire for more data protection and privacy on the Internet is in line with Dwinity's mission. The community already numbers over 40,000 individuals worldwide.
The official launch of the data storage product, which is 100% GDPR-compliant, is scheduled for Q4/2024. The cryptocurrency DWIN, a token provided by Dwinity, is required to use the data storage and to participate in the data ecosystem where users can share their data anonymously with industries such as pharma, healthcare and others. At the same time, data owners retain full control over their data. This is enabled by cooperation with leading technology providers, in particular Nillion and STORJ. Dwinity is a proud partner of NVIDIA’s Inception Program.
"Blockchain technology is becoming a game changer, enabling users to securely share their data and social capital from social networks or use it for personal predictive AI applications. Decentralized markets for data storage are already part of the infrastructure and resources that are important for the advancement of AI technologies. With Dwinity, we will unlock this potential for Predictive AI," confirms Dr. Robin Basu, Co-Founder and COO of Dwinity.
Dwinity's next round of capital comes in the form of a private token sale
Dwinity conducted its seed financing under the EU's new Markets in Crypto-Assets Regulation (MiCAR) and is one of the first companies to use this opportunity to access the capital market. The seed round achieved a total investment of 2.4 million US dollars. The next financing will also take the form of a private token sale. In the medium term, the plan is to list on a DEX, a trading platform for cryptocurrencies, and later a central crypto exchange (CEX/ ICO) to make the DWIN token publicly tradable.
For more information, please visit https://dwinity.com
Boilerplate
Dwinity - Get the real value out of Personal Data
Dwinity unlocks the full potential of personal data with a secure, user-friendly offering that utilizes blockchain technology and can make future predictions using AI. By taking back control of their data, consumers can store their sensitive personal information with confidence and share their data with various industries. Founded in 2023, Dwinity's mission is to give power back to users over their data and create a thriving data economy where information asymmetry is finally eliminated. Dwinity is a proud partner of NVIDIA Inception Program and has partnerships with leading providers such as Nillion, Storj, Bitbond, SKW Schwarz, Annerton and others.
Social Accounts: X Instagram Telegram YouTube LinkedIn
Press Contact
Talisman Kommunikation und Imagebildung
Heike Bedrich; Mobil: 0171/5432169
Mail: hb@talisman-pr.de oder dwinity_press@talisman-pr.de
Web: https://talisman-pr.de
Company Contact
Dwinity IP GmbH
Am Haag 8, 82166 Graefelfing
Mail: press@dwinity.com; contact@dwinity.com
Web: https://dwinity.com
Registergericht AG München HRB286675, Geschäftsführer: Peter Koenig
Images

Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
INTERSPORT Austria acquires INTERSPORT Slovenia Group15.1.2026 15:16:10 CET | Press release
Strategic move strengthens market position in Central Europe, with over 500 locations in 12 countries and more than € 1 billion in sales
VORN Bioenergy announces appointments to leadership team15.1.2026 11:14:45 CET | Press release
Regensburg. VORN Bioenergy today announces the appointment of Jörg Lennertz as Chief Executive Officer and Manuel Fernández Durán as Chief Financial Officer. Jörg and Manuel together with Michael Wallis Olausson form the new management team.
Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 13:42:00 CET | Press release
Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions
ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner13.1.2026 09:00:00 CET | Press release
Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom